z-logo
open-access-imgOpen Access
Discovering Protein‐Protein Interactions Using Nucleic Acid Programmable Protein Arrays
Author(s) -
Tang Yanyang,
Qiu Ji,
Machner Matthias,
LaBaer Joshua
Publication year - 2017
Publication title -
current protocols in cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.149
H-Index - 38
eISSN - 1934-2616
pISSN - 1934-2500
DOI - 10.1002/cpcb.14
Subject(s) - nucleic acid , protein microarray , chemistry , proteome , in vitro , protein tag , computational biology , microbiology and biotechnology , biochemistry , dna microarray , biology , gene , gene expression , recombinant dna , fusion protein
We have developed a protocol enabling the study of protein‐protein interactions (PPIs) at the proteome level using in vitro–synthesized proteins. Assay preparation requires molecular cloning of the query gene into a vector that supports in vitro transcription/translation (IVTT) and appends a HaloTag to the query protein of interest. In parallel, protein microarrays are prepared by printing plasmids encoding glutathione S‐transferase (GST)‐tagged target proteins onto a carrier matrix/glass slide coated with antibody directed against GST. At the time of the experiment, the query protein and the target protein are produced separately through IVTT. The query protein is then applied to nucleic acid programmable protein arrays (NAPPA) that display thousands of freshly produced target proteins captured by anti‐GST antibody. Interactions between the query and immobilized target proteins are detected through addition of a fluorophore‐labeled HaloTag ligand. Our protocol allows the elucidation of PPIs in a high‐throughput fashion using proteins produced in vitro, obviating the scientific challenges, high cost, and laborious work, as well as concerns about protein stability, which are usually present in protocols using conventional protein arrays. © 2017 by John Wiley & Sons, Inc.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here